BA.3.2, nicknamed “Cicada,” isn’t just another blip in the COVID timeline; it’s a reminder that the virus is still evolving in unexpected ways. After first being detected in South Africa in 2024, it seemed to disappear, only to re-emerge with a heavily altered spike protein and a growing global footprint. Now identified in more than 20 countries and at least 25 U.S. states, it’s raising urgent questions about how prepared we really are.
Yet this isn’t a return to the darkest days of the pandemic. Early data suggest that while Cicada may spread efficiently and dodge some existing immunity, current vaccines still offer strong protection against severe disease. That means boosters, high-risk precautions, and testing still matter. The story of Cicada is less about panic and more about vigilance: a warning that COVID’s evolution hasn’t stopped, and neither can our attention.
